1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CANO HEALTH Aktie jetzt für 0€ handeln | |||||
| 21.05.24 | Cano Health, Inc.: Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan | 158 | PR Newswire | Emergence from Chapter 11 Expected in Third Quarter of 2024
MIAMI, May 21, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company"), a leading value-based primary care... ► Artikel lesen |
1 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 412,90 | +0,05 % | What the Options Market Tells Us About Intuitive Surgical | ||
| ROKU | 50,50 | 0,00 % | Why Roku Stock Was Tumbling This Week | ||
| ATOSSA THERAPEUTICS | 0,556 | +0,18 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for (Z)-Endoxifen and Continued Engagement with FDA on Additional Indications | SEATTLE, March 11, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| QUIDELORTHO | 26,600 | +3,10 % | QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care... ► Artikel lesen | |
| VERU | 0,519 | +0,48 % | Veru Aktie: Kreuzung ohne klare Richtung! | Die Veru-Aktie konnte im jüngsten Handel einen leichten Aufschwung verzeichnen. Am 22. März stieg der Kurs um 2,35% auf 0,48 EUR, was eine positive Entwicklung gegenüber dem Vortagsschluss darstellt.... ► Artikel lesen | |
| CENTENE | 57,32 | +1,24 % | Cantor Fitzgerald maintains Overweight on Centene shares, $90 target | ||
| TEMPEST THERAPEUTICS | 0,588 | +4,53 % | Tempest Therapeutics: Tempest Reports Year End 2024 Financial Results and Provides Business Update | • Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma (HCC)• Announced Agreement with Roche to Support Advancement... ► Artikel lesen | |
| NANO-X IMAGING | 4,375 | -6,32 % | Nano-X Imaging LTD.: Nanox Announces Fourth Quarter of 2024 Financial Results and Provides Business Updates | Recorded noted regulatory successes with FDA general use clearance and granting of CE Mark in the EU Advanced commercialization globally, signing new customer and channel partner agreements for... ► Artikel lesen | |
| FULGENT GENETICS | 15,300 | -0,65 % | Fulgent Reports Third Quarter 2024 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen | |
| LANTHEUS | 82,70 | -0,36 % | Lantheus Holdings, Inc.: Lantheus Completes Acquisition of Evergreen Theragnostics | BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 1,700 | +3,66 % | Perspective Therapeutics Aktie: Erfreuliche Ergebnisse bekanntgegeben! | Das Führungsteam des Medizintechnikunternehmens demonstriert Vertrauen durch signifikante Aktienkäufe, während Experten trotz Kursrückgang hohes Wachstumspotential prognostizieren. Die Führungsriege... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 17,600 | -16,19 % | JMP maintains AMN Healthcare stock at Market Outperform with $33 target | ||
| OMNICELL | 29,400 | -2,00 % | Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy and nursing care delivery... ► Artikel lesen | |
| ALPHATEC | 8,950 | +4,68 % | Alphatec Holdings, Inc. - 8-K, Current Report |
CANO HEALTH INC gehört der Branche Gesundheitswesen an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANO HEALTH INC finden Sie auf Wallstreet Online.
